These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 15338198

  • 1. Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.
    Samani KK, Brazier M, Mathiot C, Kamel S, Jamart J, Jaubert J, Blanc M, Azaïs I, Facon T, Leleu X.
    Ann Hematol; 2005 Jan; 84(1):19-24. PubMed ID: 15338198
    [Abstract] [Full Text] [Related]

  • 2. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A, Jackson B, Pfeiffer D, Ingham K, Horton MA, Price JS.
    Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
    [Abstract] [Full Text] [Related]

  • 3. Biochemical markers of bone turnover in diagnosis of myeloma bone disease.
    Dizdar O, Barista I, Kalyoncu U, Karadag O, Hascelik G, Cila A, Pinar A, Celik I, Kars A, Tekuzman G.
    Am J Hematol; 2007 Mar; 82(3):185-91. PubMed ID: 17022050
    [Abstract] [Full Text] [Related]

  • 4. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
    Del Campo MT, González-Casaus ML, Aguado P, Bernad M, Carrera F, Martínez ME.
    Osteoporos Int; 1999 Mar; 9(5):449-54. PubMed ID: 10550465
    [Abstract] [Full Text] [Related]

  • 5. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
    Fassbender WJ, Gödde M, Brandenburg VM, Usadel KH, Stumpf UC.
    Adv Med Sci; 2009 Mar; 54(1):1-6. PubMed ID: 19482729
    [Abstract] [Full Text] [Related]

  • 6. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
    Tosi P, Zamagni E, Cellini C, Parente R, Cangini D, Tacchetti P, Perrone G, Ceccolini M, Boni P, Tura S, Baccarani M, Cavo M.
    Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429
    [Abstract] [Full Text] [Related]

  • 7. [Monitoring markers of bone turnover in multiple myeloma].
    Spicka I, Spacek P, Hulejová H, Procházka B, Cieslar P, Chrz M, Válková V, Klener P.
    Vnitr Lek; 1999 Aug; 45(8):463-7. PubMed ID: 11045145
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of pamidronate on excretion of pyridinium crosslinks of collagen after total hip arthroplasty.
    Wilkinson JM, Jackson B, Eastell R.
    Calcif Tissue Int; 2003 Oct; 73(4):326-31. PubMed ID: 12874697
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients.
    Alexandrakis MG, Passam FH, Malliaraki N, Katachanakis C, Kyriakou DS, Margioris AN.
    Clin Chim Acta; 2002 Nov; 325(1-2):51-7. PubMed ID: 12367766
    [Abstract] [Full Text] [Related]

  • 14. Variability of collagen crosslinks: impact of sample collection period.
    Smith SM, Dillon EL, DeKerlegand DE, Davis-Street JE.
    Calcif Tissue Int; 2004 Apr; 74(4):336-41. PubMed ID: 15255070
    [Abstract] [Full Text] [Related]

  • 15. Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen.
    Pecherstorfer M, Seibel MJ, Woitge HW, Horn E, Schuster J, Neuda J, Sagaster P, Köhn H, Bayer P, Thiébaud D, Ludwig H.
    Blood; 1997 Nov 01; 90(9):3743-50. PubMed ID: 9345061
    [Abstract] [Full Text] [Related]

  • 16. Bone resorption in anorexia nervosa and rehabilitated patients.
    Valtueña S, Di Mattei V, Rossi L, Polito A, Cuzzolaro M, Branca F.
    Eur J Clin Nutr; 2003 Feb 01; 57(2):260-5. PubMed ID: 12571657
    [Abstract] [Full Text] [Related]

  • 17. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.
    Papatheofanis FJ.
    J Nucl Med; 1997 Aug 01; 38(8):1175-9. PubMed ID: 9255144
    [Abstract] [Full Text] [Related]

  • 18. Urinary markers of altered collagen metabolism in fibromyalgia patients.
    Ribel-Madsen S, Christgau S, Gronemann ST, Bartels EM, Danneskiold-Samsøe B, Bliddal H.
    Scand J Rheumatol; 2007 Aug 01; 36(6):470-7. PubMed ID: 18092271
    [Abstract] [Full Text] [Related]

  • 19. Urinary markers of type I collagen degradation in the dog.
    Allen MJ, Allen LC, Hoffmann WE, Richardson DC, Breur GJ.
    Res Vet Sci; 2000 Oct 01; 69(2):123-7. PubMed ID: 11020362
    [Abstract] [Full Text] [Related]

  • 20. Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption.
    Asaba Y, Hiramatsu K, Matsui Y, Harada A, Nimura Y, Katagiri N, Kobayashi T, Takewaka T, Ito M, Niida S, Ikeda K.
    Bone; 2006 Dec 01; 39(6):1276-82. PubMed ID: 16942925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.